Activating RNA, mastering disease.

ABOUT MiNA

Harnessing the innate mechanism of gene activation, MiNA Therapeutics’ platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape in cancer and other diseases.

NEW CLASS OF MEDICINES

Small activating RNAs are an entirely new class of medicines with potential to offer transformational benefits to patients across a wide range of diseases.

CLINICAL STAGE PLATFORM

We have developed a systematic approach to take new saRNA medicines from an idea to patients in a clinical trial in just 2 years.

EXPERIENCED TEAM

Driving our platform are a group of passionate scientists, drug developers, doctors and entrepreneurs shaped by experience in oligonucleotide therapeutics, oncology and immunology.

TWITTER FEED

Follow us on Twitter

We are thrilled to join forces with @Servier to tackle neurological disorders. This partnership will combine our profound #saRNA technology expertise with Servier’s disease-specific insights to develop new therapies for patients. More here: https://t.co/Y6h55jWERf

Load More...

By continuing to use this site you are agreeing only to the use of cookies that are strictly necessary for the running of our website. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close